You are here: Home / Products
suPARnostic® is the only CE-IVD certified product range applied for clinical determination of suPAR (soluble uPAR) in human plasma and serum.
suPAR is a universal and broadly applicable prognostic biomarker of chronic inflammation and immune activation across diseases and can be used for risk stratification of acute medical patients.
Important clinical benefits include:
- Identification of patients who can be discharged after treatment
- Helps to prioritize patients and reduce Emergency Department crowding
- Add to clinical decisions
- Advance identification of high-risk patients with unaffected vital signs
suPARnostic® also improves the efficiency of the Emergency Department by shortening the average patient-length-of-stay which lead to cost savings.